Overview
The marketing authorisation for Poulvac FluFend H5N3 RG has been withdrawn at the request of the marketing authorisation holder.
Poulvac Flufend H5N3 RG : EPAR - Summary for the public
Product information
Poulvac Flufend H5N3 RG : EPAR - Product Information
Latest procedure affecting product information: R/0010
30/03/2012
Poulvac Flufend H5N3 RG : EPAR - All Authorised presentations
Product details
- Name of medicine
- Poulvac Flufend H5N3 RG
- Active substance
- recombinant inactivated avian influenza virus
- International non-proprietary name (INN) or common name
- recombinant inactivated avian influenza virus
- Species
- Chicken
- Ducks
- Anatomical therapeutic chemical veterinary (ATCvet) code
- QI01AA23
Pharmacotherapeutic group
ImmunologicalsTherapeutic indication
For active immunisation of chickens and ducks against avian influenza virus type A, subtype H5.
Chickens:
Reduction of mortality and virus excretion after challenge.
Onset of immunity: 3 weeks after the second injection.
Duration of immunity in chickens has not been established yet.
Ducks:
Reduction of clinical signs and virus excretion after challenge.
Onset of immunity: 3 weeks after the second injection.
Duration of immunity in ducks : 14 weeks after the second injection.
Assessment history
Poulvac Flufend H5N3 RG : EPAR - Procedural steps taken and scientific information after authorisation